NCT00156650View on ClinicalTrials.gov

Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Contraception
Interventions
DRUG

Acyline

Acyline 300 mcg/kg SQ(Subcutaneously)twice monthly for 12 weeks

DRUG

Testosterone Gel

Testosterone (T) gel 10 g daily for 6 months

DRUG

Depo-Medroxyprogesterone

300 mg IM every 3 months

Trial Locations (1)

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Washington

OTHER

NCT00156650 - Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum | Biotech Hunter | Biotech Hunter